Accustem Sciences Inc. (ACUT) stock
ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.15+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.37MP/E –Yield –
Accustem Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $98.40K | – |
See a number that looks wrong?